Description

MT-1 10MG

We provide MT-1 as a 10MG synthetic tridecapeptide research compound with a stated 99.1% purity. Furthermore, MT-1 corresponds to Melanotan I, also known as afamelanotide, a modified analog of α-melanocyte-stimulating hormone (α-MSH). Consequently, researchers have investigated its interaction with melanocortin receptors, particularly MC1R, alongside downstream melanogenesis, cAMP signaling, and pigmentation pathways. PubChem identifies afamelanotide as a 13-amino-acid α-MSH analog with a molecular weight of 1,646.8 g/mol.

MT-1 Key Attributes

• Brand: AvigenLab
• Product Name: MT-1
• Alternative Name: Melanotan I / Afamelanotide
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Tridecapeptide
• Sequence Length: 13 Amino Acids
• Sequence: Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂
• Molecular Formula: C₇₈H₁₁₁N₂₁O₁₉
• Molecular Weight: 1,646.8 g/mol
• CAS Number: 75921-58-5
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

PubChem records the molecular formula, molecular weight, sequence, and structural identity of afamelanotide/Melanotan I.

MT-1 Product Overview

We provide MT-1 for research involving melanocortin receptor signaling, melanocyte biology, eumelanin production, cAMP-mediated pathways, and pigmentation research. Moreover, the European Medicines Agency describes afamelanotide as a synthetic tridecapeptide and structural α-MSH analog that binds predominantly to MC1R.

Additionally, MC1R activation stimulates intracellular cAMP signaling and promotes pathways associated with eumelanin synthesis. Therefore, researchers can investigate the relationship between receptor activation, melanocyte signaling, tyrosinase activity, and pigment production under controlled experimental conditions.

Researchers can explore additional research materials through our Online Store.

MT-1 Product Identification

We identify MT-1 through its 10MG quantity, synthetic tridecapeptide classification, stated 99.1% purity, and vial presentation. Furthermore, the molecular sequence incorporates the Nle4 and D-Phe7 modifications associated with Melanotan I. Consequently, researchers can distinguish the compound from Melanotan II and other α-MSH analogs according to its structure and molecular characteristics.

Product Category

We classify the material within our research peptide collection for melanocortin pharmacology, pigmentation biology, melanogenesis, receptor signaling, and photobiology research.

Moreover, research has demonstrated that melanocortin peptides interact with MC1R and stimulate cAMP formation, tyrosinase activity, and melanogenesis in human melanocytes. Likewise, studies examining Melanotan I have investigated pigmentation responses and pharmacokinetic characteristics in controlled research settings.

You can review related materials through our Catalog.

Scientific Characteristics

The molecule contains 13 amino acids and represents a structurally modified α-MSH analog. In particular, the Nle4 and D-Phe7 substitutions contribute to its distinct receptor-binding and stability characteristics compared with endogenous α-MSH. Furthermore, PubChem lists a molecular formula of C₇₈H₁₁₁N₂₁O₁₉ and molecular weight of 1,646.8 g/mol.

Meanwhile, MC1R functions as a G-protein-coupled receptor on melanocytes. Consequently, receptor activation can stimulate adenylate cyclase, increase intracellular cAMP, and promote signaling associated with eumelanin production.

Research Applications

We position MT-1 for research involving MC1R signaling, melanogenesis, eumelanin biosynthesis, cAMP pathways, tyrosinase activity, melanocyte biology, pigmentation research, and photoprotection mechanisms.

Additionally, experimental research has examined Melanotan I for its effects on pigmentation and its pharmacokinetic characteristics following different routes of administration. Likewise, research into α-MSH analogs has demonstrated direct relationships between MC1R activation, cAMP formation, tyrosinase activity, and melanogenesis.

Furthermore, the European Medicines Agency describes afamelanotide as activating eumelanin synthesis through MC1R and notes the photoprotective properties associated with eumelanin.

Product Configuration

We provide MT-1 in a 10MG vial carrying a stated 99.1% purity designation. Accordingly, the defined quantity, peptide identity, purity specification, and physical presentation establish straightforward reference points for laboratory inventory.

Additionally, the individual-peptide configuration distinguishes this presentation from MT-2 and other melanocortin-related products. Therefore, researchers can organize the material according to its specific molecular identity, quantity, and physical format.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, 13-amino-acid structure, and clearly defined research-use presentation. Moreover, our product label communicates Not For Human Use | Research Use Only.

Furthermore, the compound’s established relationship with MC1R, cAMP signaling, and melanogenesis provides a strong scientific basis for pigmentation-focused research. Consequently, researchers can examine receptor activation and downstream melanocyte responses using a defined molecular subject.

Product Specifications

The molecular identity and chemical specifications correspond with the afamelanotide/Melanotan I structure recorded by PubChem.

Intended Research Context

We classify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory research rather than consumer or therapeutic applications.

In particular, researchers can investigate MC1R receptor activity, melanocyte signaling, eumelanin synthesis, cAMP pathways, tyrosinase-related mechanisms, and pigmentation biology. Moreover, published research establishes MC1R activation as an important component of human melanogenesis.

Nevertheless, researchers should distinguish molecular and cellular findings from broader clinical conclusions. Afamelanotide has also been developed as a pharmaceutical treatment for erythropoietic protoporphyria, but that regulatory status concerns approved pharmaceutical formulations rather than this AvigenLab research presentation.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging displays the 10MG quantity, communicates the stated 99.1% Purity, and identifies the material as Not For Human Use | Research Use Only.

Additionally, the vial format provides straightforward identification within our research catalog. Researchers can also review our broader Product Collection.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, published research concerning afamelanotide does not constitute regulatory approval for this specific AvigenLab research presentation.

Moreover, afamelanotide itself has received regulatory approval for a specific medical indication in certain jurisdictions. The European Medicines Agency identifies it as an approved treatment for adult patients with erythropoietic protoporphyria.

Consequently, we distinguish the established pharmaceutical history of the active compound from the research classification of our 10MG product.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Furthermore, researchers should maintain appropriate laboratory handling practices and follow product-specific documentation.

Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters. Consequently, researchers can rely on applicable product documentation rather than generalized assumptions.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our collection. The quantity, stated purity, molecular identity, 13-amino-acid classification, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Moreover, Melanotan I has a substantial scientific history within melanocortin and pigmentation research. Research has examined its receptor activity, pharmacokinetics, pigmentation effects, and relationship with melanocyte signaling.

Product Reference

Our MT-1 10MG presentation provides a defined synthetic tridecapeptide carrying a stated 99.1% purity designation. We document the material according to its molecular sequence, structural characteristics, MC1R research relevance, vial configuration, and Research Use Only classification.

Consequently, the product provides researchers with a clearly identified material for investigating melanocortin receptor signaling, cAMP-mediated melanogenesis, eumelanin production, melanocyte biology, and related pigmentation mechanisms. Furthermore, the extensive scientific literature surrounding Melanotan I provides a strong reference base for continued investigation into the relationship between MC1R activation and pigment production.

For additional product information, researchers can also visit our Shop.